PCT types and Number of studies (%) | Outcome measures | Process measures | ||
---|---|---|---|---|
Clinical outcome measures | Patient-reported outcomes and experiences | Changes in patient behaviors | ||
Upward PCT 7 (41.2%) | Positive results: - Lower severity in depression (SCL-20); improvements in anxiety, quality of life, role functioning [49]; - Lower PHQ-9 scores and HbA1c [52]; - Less depression, anxiety, pain, and fatigue; better functioning and quality of life [48]; - Lower in glycated hemoglobin levels, LDL cholesterol levels, systolic BP, SCL-20; better quality of life [44]; - Less severity of depression [40] Negative results: - No significant difference in BP, quality of life [52]; - No significant difference in reduction of PHQ-9 score, BP, BMI, waist circumference [46]; - No significant difference in HbA1c levels [40] | Positive results: - Improvements in self-rated depression, perceived quality of care [49]; - Better perceived quality of depression care, overall health [48]; - Greater satisfaction with care for diabetes, CAD or both and care for depression [44]; - Greater satisfaction with care, higher self-rated global improvement [40] Negative results: - Not reported | Positive results: - Increased monitoring of BP and glucose Negative results: - No significant difference in smoking [46]; - No significant difference in medication adherence [41] | Positive results: - Increased anti-depressants, insulin and antihypertensive medications initiation and adjustment [41]; - Increased insulin adjustments, antihypertensive medications and antidepressants [44]; - Greater improvements in adequacy of dosage of antidepressant medication treatment [40] Negative results: - No significant difference in receipt of counselling, receipt of antidepressant treatment [46] |
Downward PCT 2 (11.8%) | Positive results: - Greater improvements in serum CRP level [47] - Greater improvements in PHQ-9 [43] Negative results: - No significant difference in changes of systolic BP43; - No significant difference in LDL, HbA1c, BMI [47]; | Not reported | Positive results: - Greater improvements in self-reported salt intake [47]; Negative results: - No significant difference in antithrombotic adherence, physical activity level, diet, smoking status [47] | Positive results: - Increased identification of depression and alcohol use disorder [43] Negative results: Not reported |
Traditional PCT 8 (47.1%) | Positive results: - Improvements in BP control and total cholesterol control in high-risk patients [50]; - Improvements in depression [42]; - Improvements in depression, anxiety [36]; - Improved mental components [37]; - Lower severity of depression, higher response rate to antidepressant treatment and remission rate [34]; - Improved quality of life [37] Negative results: - No significant difference in quality of life, number of deaths or illness burden [45]; - No significant difference in all-cause hospitalizations [37]; - No significant difference in quality of life, self-efficacy, or disability [36]; - No significant difference in pain severity or pain response rate [34] | Positive results: - Improvements in patient-centeredness [45]; - Improvements in general health [37]; - Improved satisfaction with care, more patient-centered [36] Negative results: - No significant difference in illness perceptions or social support [36] | Positive results: - Reduced consumption of saturated fat, increased consumption of fruit, vegetables, and oily fish [50]; - Increased exercise, increased visits to mental health workers [42]; - Lower hospitalizations for ambulatory care sensitive conditions [38]; - Better in self-management [36] Negative results: - No significant difference in hospital admissions or outpatient attendances [45]; - No significant change in smoking [50] | Positive results: - More prescriptions of statins, angiotensin-converting enzyme inhibitors [50]; - Improvement in the Continuity of Care Index [45]; - Increased referrals to exercise program, mental health workers [42]; - Increased self-management plan formulation, assessment of smoking status, measuring BMI [35]; - More consultations [45] Negative results: - No significant difference in quality of disease management and high-risk prescribing [45]; - Decreased testing for LDL; no significant difference in testing for HbA1C, HgbA1C, LDL, and BP [35] |